Abstract
Gangliosides are glycolipids occurring in higher animals, with a sphingoid core in the form of ceramide, bound to a glycan moiety including several units of sialic acid. Gangliosides are involved in important (patho)-physiological processes as components of cell membranes in humans, which has led to intensive study and interest in production strategies. Their structural variability depends on the combination of a sphingoid base, a fatty acyl chain, and an attached oligosaccharide. The combinatorial diversity differs and grows exponentially in synthetic biology approaches, e.g., use of microbial cell factories. A specific analytical platform accounting for this complexity is not available to date. However, quantification of the intermediates of the whole biosynthetic route is needed to boost projects on biotechnological ganglioside production. In this study, a fast high-throughput quantitative LC-MS/MS methodology was developed to cover analysis of gangliosides, with a wider structural perspective adapted to fungal organisms. This work was achieved using metabolically engineered strains that further allowed to test detection in biological complex matrixes. Ganglioside backbones—hitherto uncharacterized—with the five most common fungal sphingoid bases and both simple and hydroxylated fatty acids were subjected to characterization. The addition of glycans to the polar head was also successfully monitored with up to 4 units—corresponding to GD3 which bears two sialic acid units and furthermore represents the common precursor for the whole ganglio-series. This platform represents an improved methodology to study the biochemical diversity associated to gangliosides for natural and metabolically engineered biosynthetic pathways.
Funder
Spanish Ministerio de Ciencia e Innovación
Spanish Ministerio de Economía y Competitividad
University of Salamanca
Subject
Filtration and Separation,Analytical Chemistry
Reference26 articles.
1. Sphingolipids and gangliosides of the nervous system in membrane function and dysfunction;Sipione;FEBS Lett.,2010
2. Gangliosides in cell recognition and membrane protein regulation;Lopez;Curr. Opin. Struct. Biol.,2009
3. Ganglioside metabolism in health and disease;Sandhoff;Prog. Mol. Biol. Transl. Sci.,2018
4. Fazzari, M., Lunghi, G., Chiricozzi, E., Mauri, L., and Sonnino, S. (2022). Gangliosides and the treatment of neurodegenerative diseases: A long italian tradition. Biomedicines, 10.
5. Gangliosides: Treatment avenues in neurodegenerative disease;Magistretti;Front. Neurol.,2019